AWAKN is a UK and European focused company that is dedicated to integrating psychedelics into mental healthcare. The company work sacross three business lines: Clinical research, therapeutic clinics and practitioner training.
On-demand research and clinical trials – study design, enrollment, execution – for the medicalisation of psychedelic assisted therapy. Advancing mental health through pre-clinical, Phase I-III, regulatory submissions and IP creation.
A revolutionary shift in the treatment approach for mental health disorders, under the leadership of psychiatric specialist, researcher, author and clinic founder, Dr. Ben Sessa.
Innovative psychedelic training for Psychiatrists and Psychologists to pivot into the future of mental health disorder treatments.
Chief Executive Officer
Dr. Ben Sessa
Chief Medical Officer
Chief Financial Officer